Structurally diverse alkaloids from Buxus sempervirens with cardioprotective activity
Zhi-Nan Xiang1, Jun-Cheng Su2, Yi-Hui Liu3
1Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
Researchers identified 17 Buxus alkaloids, including 12 new compounds, from Buxus sempervirens. Some new alkaloids showed significant protective effects against doxorubicin-induced cardiac injury in preliminary bioactivity assessments.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Buxus sempervirens (boxwood) is a source of structurally diverse alkaloids with potential medicinal properties.
- Previous research has identified various Buxus alkaloids, but novel structures and bioactivities continue to be discovered.
Purpose of the Study:
- To conduct an extensive phytochemical investigation of the methanol extract of Buxus sempervirens twigs and leaves.
- To isolate, identify, and characterize new Buxus alkaloids.
- To evaluate the bioactivity of the isolated compounds, particularly their protective effects in a doxorubicin-induced cardiac injury model.
Main Methods:
- Phytochemical analysis of the methanol extract using High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS) and Nuclear Magnetic Resonance (NMR) spectroscopy.
- Structure elucidation aided by detailed spectroscopic data analysis and quantum chemical NMR calculations.
- In vitro bioactivity assessment using a doxorubicin-induced cardiac injury model.
Main Results:
- Isolation and identification of 17 Buxus alkaloids, with 12 novel compounds designated as buxusemines A-L (1-12).
- Characterization of unique structural motifs in new alkaloids, including a spiro[4.6]undecatriene moiety (buxusemine A), an additional five-membered ring (buxusemines B-C), and an epoxy motif (buxusemines D-F).
- Buxusemine F (6) and buxanoldine (17) demonstrated superior protective effects against doxorubicin-induced cardiotoxicity compared to the positive control, cyclovirobuxinum D.
Conclusions:
- The study successfully identified a significant number of new Buxus alkaloids from Buxus sempervirens, expanding the known chemical diversity of this genus.
- Buxusemine F and buxanoldine show promising cardioprotective potential, warranting further investigation for therapeutic applications in managing drug-induced cardiac injury.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
